Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+1.6M
-
Total reported value, excl. options
-
$86.2M
-
Value change
-
+$4.85M
-
Number of buys
-
36
-
Number of sells
-
-24
-
Price
-
$3.24
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2017
70 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q2 2017.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 114M outstanding shares and own 23.28% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (6.08M shares), FMR LLC (4.35M shares), EcoR1 Capital, LLC (2.54M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), BlackRock Inc. (1.66M shares), Redmile Group, LLC (1.42M shares), VANGUARD GROUP INC (1.26M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.15M shares), MORGAN STANLEY (634K shares), and 683 Capital Management, LLC (588K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.